In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Buy rating on AstraZeneca (AZN – Research Report), with a ...

The first Christmas campaigns started in earnest last week, so it must be September. Murdoch makes money moves Rightmove ...

When “the Greater Good” Matters The business pages, and now the mainstream media, have been dominated over the last week with news of Pfizer’s proposed $106bn takeover of AstraZeneca, which would make ...

Sharma’s analysis would have taken into account AstraZeneca’s financial metrics, market dynamics, and potential for shareholder value creation, leading to his positive outlook on the company’s stock.

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...

As a comparator, AstraZeneca used Imfinzi before surgery followed by no ... This effect was statistically significant, with a ...

Two of the simplest ways to measure the success of companies that develop and commercialize drugs is to count their approvals ...

Panelists discussed how the Inflation Reduction Act and the Enhancing Oncology Model are impacting value in cancer care and ...

Fidelity Value Discovery Fund is a large-cap, value-oriented strategy that seeks capital appreciation. For the three months ...

Bronchoscopic lung volume reduction (BLVR) was associated with sustained improvements in adults with severe emphysema over a 5-year period, based on data from 190 individuals. The LIBERATE study, a ...

Shares in Astrazenca and Daiichi Sankyo nose dived today after the pair revealed mixed results in their lung cancer drug's ...

Several AstraZeneca staff are under investigation in China for allegedly breaking the law. The UK pharma giant said five current and former workers were being questioned. Bloomberg reported that ...